PL2588083T3 - Rusztowania biomacierzowe - Google Patents
Rusztowania biomacierzoweInfo
- Publication number
- PL2588083T3 PL2588083T3 PL11801493T PL11801493T PL2588083T3 PL 2588083 T3 PL2588083 T3 PL 2588083T3 PL 11801493 T PL11801493 T PL 11801493T PL 11801493 T PL11801493 T PL 11801493T PL 2588083 T3 PL2588083 T3 PL 2588083T3
- Authority
- PL
- Poland
- Prior art keywords
- biomatrix scaffolds
- biomatrix
- scaffolds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0671—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/28—Materials or treatment for tissue regeneration for liver reconstruction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/14—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20051—Methods of production or purification of viral material
- C12N2710/20052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10151—Methods of production or purification of viral material
- C12N2730/10152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24223—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24251—Methods of production or purification of viral material
- C12N2770/24252—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Prostheses (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36093910P | 2010-07-02 | 2010-07-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2588083T3 true PL2588083T3 (pl) | 2017-08-31 |
Family
ID=45402468
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11801493T PL2588083T3 (pl) | 2010-07-02 | 2011-07-01 | Rusztowania biomacierzowe |
PL11801504T PL2588027T3 (pl) | 2010-07-02 | 2011-07-01 | Rusztowania biomacierzowe do rozpraszania na skalę przemysłową |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11801504T PL2588027T3 (pl) | 2010-07-02 | 2011-07-01 | Rusztowania biomacierzowe do rozpraszania na skalę przemysłową |
Country Status (12)
Country | Link |
---|---|
US (7) | US8802081B2 (pl) |
EP (6) | EP3216444B1 (pl) |
JP (7) | JP6308781B2 (pl) |
CN (4) | CN103491898B (pl) |
DK (2) | DK2588083T3 (pl) |
ES (6) | ES2626145T3 (pl) |
HK (2) | HK1243928A1 (pl) |
HU (2) | HUE032727T2 (pl) |
LT (2) | LT2588083T (pl) |
PL (2) | PL2588083T3 (pl) |
PT (2) | PT2588083T (pl) |
WO (2) | WO2012003463A1 (pl) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6308781B2 (ja) * | 2010-07-02 | 2018-04-11 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルThe University Of North Carolina At Chapel Hill | バイオマトリックス足場 |
NL2009145C2 (en) * | 2012-07-06 | 2014-01-07 | Xeltis B V | Implant. |
CN103536967B (zh) * | 2012-07-10 | 2016-04-13 | 上海微创医疗器械(集团)有限公司 | 一种制备细胞外基质支架材料的脱细胞方法 |
US9533013B2 (en) | 2013-03-13 | 2017-01-03 | University Of North Carolina At Chapel Hill | Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree |
PT2968418T (pt) * | 2013-03-15 | 2024-01-11 | Nutech Medical Inc | Preparações derivadas de materiais placentários e produção e utilização das mesmas |
KR20230061578A (ko) * | 2013-03-15 | 2023-05-08 | 미로매트릭스 메디칼 인크. | 섬 세포 재세포화를 위한 관류 탈세포화된 간의 용도 |
WO2014168964A1 (en) * | 2013-04-08 | 2014-10-16 | Asana Medical, Inc. | Method and composition for treating inflammatory bowel disease without colectomy |
US20150037436A1 (en) | 2013-07-30 | 2015-02-05 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
CN103432627B (zh) * | 2013-08-26 | 2015-03-25 | 北京瑞健高科生物科技有限公司 | 一种制备动物脱细胞组织基质材料的方法及其制备的组织基质材料 |
GB201409858D0 (en) * | 2014-06-03 | 2014-07-16 | Ucl Business Plc | Human liver scaffolds |
CN104288837B (zh) * | 2014-09-11 | 2016-04-13 | 杨淑珍 | 一种脱细胞真皮基质及其制备方法和用途 |
CA2977520A1 (en) | 2015-02-27 | 2016-09-01 | Salk Institute For Biological Studies | Reprogramming progenitor compositions and methods of use therefore |
CN104928241B (zh) * | 2015-03-27 | 2018-04-13 | 北京康爱瑞浩生物科技股份有限公司 | 一种增强型nk细胞的活化方法及细胞制备方法 |
EP3307874A4 (en) | 2015-06-12 | 2019-04-24 | Agency For Science, Technology And Research | DERIVATION OF HEPATIC STEM CELLS AND TYPES OF HEPATIC CELLS AND ASSOCIATED USES THEREOF |
US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
CN106884002B (zh) * | 2015-12-15 | 2021-03-19 | 上海市针灸经络研究所 | 一种稳定的结肠上皮细胞培养方法 |
CN105833353B (zh) * | 2016-05-09 | 2018-04-20 | 拜欧迪赛尔(北京)生物科技有限公司 | 一种生物工程脱细胞真皮基质的制备及用途 |
US20170369849A1 (en) * | 2016-05-11 | 2017-12-28 | The University Of North Carolina At Chapel Hill | Compositions and methods for bioengineered tissues |
JP7178264B2 (ja) | 2016-05-25 | 2022-11-25 | ソーク インスティチュート フォー バイオロジカル スタディーズ | オルガノイド作製および疾患モデル化のための組成物および方法 |
RU2019103382A (ru) * | 2016-07-12 | 2020-08-11 | Те Юниверсити Оф Норт Каролина Эт Чепел Хилл | Биоматриксные скаффолды, предназначенные для применения при диагностировании и моделировании рака |
CN106362212A (zh) * | 2016-10-21 | 2017-02-01 | 华中科技大学同济医学院附属协和医院 | 一种用于去除组织细胞的亲脂性去细胞溶液、试剂盒和方法 |
GB2555787A (en) * | 2016-11-07 | 2018-05-16 | Landberg Goran | Diagnostic methods |
CN110023761B (zh) * | 2016-11-30 | 2023-05-05 | 布鲁克·道尔顿有限及两合公司 | 制备活的微生物样品和微生物用于随后的质谱测量和评估 |
MX2019014912A (es) * | 2017-06-12 | 2020-08-06 | Univ North Carolina Chapel Hill | Composiciones de injerto tipo parche para injerto de células. |
CN111050697A (zh) * | 2017-07-31 | 2020-04-21 | 亚历山大·多坎托·扎戈 | 促进快速支柱覆盖和血管内皮覆盖的装置和方法 |
EP3470096A1 (en) * | 2017-10-13 | 2019-04-17 | Erasmus University Medical Center Rotterdam | Elastin reduction allowing recellularization of cartilage implants |
WO2019129646A1 (en) * | 2017-12-29 | 2019-07-04 | F. Hoffmann-La Roche Ag | Tissue sample preparation system |
US20210187032A1 (en) * | 2018-05-14 | 2021-06-24 | Roosterbio, Inc. | Methods and compositions related to extracellular material derived from hypertonic cell solutions |
CN108753687B (zh) * | 2018-06-22 | 2021-04-16 | 中国人民解放军军事科学院军事医学研究院 | 微肝组织培养模型、其构建方法及其应用 |
CN108753686B (zh) * | 2018-06-22 | 2021-06-22 | 中国人民解放军军事科学院军事医学研究院 | 组织工程肝脏模型、其构建方法及其应用 |
CN109735490A (zh) * | 2019-03-06 | 2019-05-10 | 福建省海西细胞生物工程有限公司 | 一种脂肪干细胞提取方法 |
CN110257335B (zh) * | 2019-04-10 | 2020-09-29 | 首都医科大学附属北京天坛医院 | 单层或多层的3d脑胶质瘤细胞培养模型及其构建方法和应用 |
KR20220045932A (ko) | 2019-05-16 | 2022-04-13 | 레스메드 피티와이 엘티디 | 의료용 디바이스의 양방향 통신 |
KR102348063B1 (ko) * | 2019-09-04 | 2022-01-10 | 한국생명공학연구원 | 증식 가능한 간 오가노이드 분화용 배지 조성물 및 이를 이용한 간 오가노이드의 제조방법 |
CN110559485B (zh) * | 2019-09-25 | 2021-02-02 | 北京大清生物技术股份有限公司 | 一种生物组织基质材料及其制备方法与应用 |
DE102019130568A1 (de) | 2019-11-13 | 2021-05-20 | Aesculap Ag | Chirurgischer Fräser mit verbesserter Spanabfuhr |
CN111110919A (zh) * | 2019-12-30 | 2020-05-08 | 广东泓志生物科技有限公司 | 大网膜脱细胞基质材料的制备方法及软骨组织的构建方法 |
US20230067199A1 (en) * | 2020-02-14 | 2023-03-02 | Cellartgen Inc. | Organ extracellular matrix-derived scaffold for culture and transplantation of organoid and method of preparing the same |
CN111760072B (zh) * | 2020-08-24 | 2022-09-23 | 鲁峰 | 脂肪来源的真皮内填充物及其制备和应用 |
CN114748208B (zh) * | 2022-04-15 | 2024-01-12 | 柔脉医疗(深圳)有限公司 | 一种可原位检测多种化学、生物成分的组织工程支架 |
CN115948331A (zh) * | 2022-10-17 | 2023-04-11 | 中国人民解放军西部战区总医院 | 一种从小鼠胆囊中分离获取间充质干细胞的方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19569C (de) | ANNA ERBER in Brieg | Neuerungen an der unter Nr. 17581 patentirten Handlaterne | ||
EP0682671A4 (en) | 1993-02-01 | 1998-01-14 | Seq Ltd | METHOD AND DEVICES FOR SEQUENCING DNA. |
US5695998A (en) | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
US6149891A (en) | 1995-05-31 | 2000-11-21 | Israel Humanitarian Foundation Ltd. | X-ray contrast medium and method for protecting against harmful effects thereof |
US20020177551A1 (en) * | 2000-05-31 | 2002-11-28 | Terman David S. | Compositions and methods for treatment of neoplastic disease |
CA2419817C (en) | 2000-08-16 | 2014-11-18 | Duke University | Decellularized tissue engineered constructs and tissues |
KR101132545B1 (ko) | 2001-02-14 | 2012-04-02 | 안트로제네시스 코포레이션 | 산후 포유류의 태반, 이의 용도 및 태반 줄기세포 |
AU2002320189B2 (en) * | 2001-06-28 | 2007-04-26 | Cook Biotech Incorporated | Graft prosthesis devices containing renal capsule collagen |
US20040187877A1 (en) * | 2002-12-04 | 2004-09-30 | Badylak Stephen F. | Method for repair of liver tissue |
WO2004076631A2 (en) * | 2003-02-21 | 2004-09-10 | The Uab Research Foundation | Biologically active native biomatrix composition |
US20050025838A1 (en) | 2003-06-25 | 2005-02-03 | Badylak Stephen F. | Conditioned compositions for tissue restoration |
US7413734B2 (en) * | 2003-06-27 | 2008-08-19 | Ethicon, Incorporated | Treatment of retinitis pigmentosa with human umbilical cord cells |
MX2007015541A (es) * | 2005-06-10 | 2008-03-06 | Celgene Corp | Composiciones de colageno de placenta humana proceso para su preparacion, metodos de uso y equipos que contienen las composiciones. |
CN101238249B (zh) * | 2005-08-10 | 2012-09-19 | 东丽株式会社 | 海绵状结构体和粉末以及它们的制造方法 |
US9944900B2 (en) | 2006-01-18 | 2018-04-17 | Hemacell Perfusion | Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells |
US8241908B2 (en) | 2006-05-16 | 2012-08-14 | Becton, Dickinson And Company | Extracellular matrix coated surface for culturing cells |
US8685107B2 (en) * | 2007-07-03 | 2014-04-01 | Histogenics Corporation | Double-structured tissue implant and a method for preparation and use thereof |
DK2349292T3 (en) * | 2008-09-30 | 2017-06-26 | Univ California | COMPOSITIONS comprising decellularized extracellular matrix obtained from cardiac tissue |
WO2010091188A1 (en) * | 2009-02-04 | 2010-08-12 | Yale University | Tissue engineering of lung |
US9277999B2 (en) * | 2009-02-27 | 2016-03-08 | University of Pittsburgh—of the Commonwealth System of Higher Education | Joint bioscaffolds |
EP2588592B1 (en) | 2010-06-30 | 2017-09-06 | Miromatrix Medical Inc. | Use of perfusion decellularized organs for matched recellularization |
JP6308781B2 (ja) * | 2010-07-02 | 2018-04-11 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルThe University Of North Carolina At Chapel Hill | バイオマトリックス足場 |
-
2011
- 2011-07-01 JP JP2013518758A patent/JP6308781B2/ja active Active
- 2011-07-01 HU HUE11801504A patent/HUE032727T2/en unknown
- 2011-07-01 US US13/807,253 patent/US8802081B2/en active Active
- 2011-07-01 ES ES11801504.9T patent/ES2626145T3/es active Active
- 2011-07-01 ES ES16191506T patent/ES2791312T3/es active Active
- 2011-07-01 PL PL11801493T patent/PL2588083T3/pl unknown
- 2011-07-01 ES ES16191501T patent/ES2879246T3/es active Active
- 2011-07-01 CN CN201180042690.1A patent/CN103491898B/zh not_active Expired - Fee Related
- 2011-07-01 EP EP16191506.1A patent/EP3216444B1/en active Active
- 2011-07-01 PL PL11801504T patent/PL2588027T3/pl unknown
- 2011-07-01 ES ES19174054T patent/ES2916580T3/es active Active
- 2011-07-01 PT PT118014935T patent/PT2588083T/pt unknown
- 2011-07-01 PT PT118015049T patent/PT2588027T/pt unknown
- 2011-07-01 DK DK11801493.5T patent/DK2588083T3/en active
- 2011-07-01 EP EP19174054.7A patent/EP3581171B1/en active Active
- 2011-07-01 JP JP2013518763A patent/JP2013539960A/ja active Pending
- 2011-07-01 ES ES19199017T patent/ES2946590T3/es active Active
- 2011-07-01 LT LTEP11801493.5T patent/LT2588083T/lt unknown
- 2011-07-01 EP EP11801504.9A patent/EP2588027B8/en not_active Not-in-force
- 2011-07-01 CN CN201510751844.4A patent/CN105713868A/zh active Pending
- 2011-07-01 EP EP16191501.2A patent/EP3192862B1/en active Active
- 2011-07-01 DK DK11801504.9T patent/DK2588027T3/en active
- 2011-07-01 CN CN201610286180.3A patent/CN106362211A/zh active Pending
- 2011-07-01 US US13/807,260 patent/US9102913B2/en active Active
- 2011-07-01 EP EP11801493.5A patent/EP2588083B1/en not_active Not-in-force
- 2011-07-01 WO PCT/US2011/042825 patent/WO2012003463A1/en active Application Filing
- 2011-07-01 EP EP19199017.5A patent/EP3603622B1/en active Active
- 2011-07-01 HU HUE11801493A patent/HUE032730T2/en unknown
- 2011-07-01 CN CN2011800426899A patent/CN103249404A/zh active Pending
- 2011-07-01 ES ES11801493.5T patent/ES2624742T3/es active Active
- 2011-07-01 WO PCT/US2011/042805 patent/WO2012003450A2/en active Application Filing
- 2011-07-01 LT LTEP11801504.9T patent/LT2588027T/lt unknown
-
2013
- 2013-06-28 HK HK18103417.9A patent/HK1243928A1/zh unknown
-
2014
- 2014-06-30 HK HK14106604.9A patent/HK1193018A1/zh not_active IP Right Cessation
- 2014-08-08 US US14/455,819 patent/US20150110753A1/en not_active Abandoned
-
2015
- 2015-10-13 US US14/813,993 patent/US9944896B2/en active Active
-
2016
- 2016-07-27 US US15/221,413 patent/US10246678B2/en active Active
- 2016-12-07 JP JP2016237355A patent/JP2017055764A/ja active Pending
- 2016-12-07 JP JP2016237356A patent/JP6612722B2/ja not_active Expired - Fee Related
-
2018
- 2018-04-12 US US15/952,094 patent/US10640747B2/en not_active Expired - Fee Related
- 2018-05-29 JP JP2018102418A patent/JP6527272B2/ja active Active
- 2018-10-12 JP JP2018193565A patent/JP2019017393A/ja active Pending
- 2018-10-12 JP JP2018193545A patent/JP2019017392A/ja active Pending
-
2019
- 2019-02-12 US US16/274,020 patent/US20200002667A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2588083T3 (pl) | Rusztowania biomacierzowe | |
SG10201606027VA (en) | Scaffolding | |
ZA201204839B (en) | Alpha-amylases | |
ZA201206766B (en) | Lance | |
AP2012006640A0 (en) | New aminopyrazoloquinazolines | |
GB0904907D0 (en) | Scaffold | |
GB201112745D0 (en) | New uses | |
EP2638210A4 (en) | SCAFFOLDING FIXATION ASSEMBLY | |
GB201120662D0 (en) | Scaffolding stabilisers | |
PL2654402T3 (pl) | Zraszacz | |
GB0904174D0 (en) | Scaffolds | |
GB2477812B (en) | Scaffolding Tool | |
GB2476305B (en) | Scaffolding | |
PL2618939T3 (pl) | Zraszacz | |
AU335302S (en) | Mattock | |
GB2486723B (en) | Shuttering | |
GB2471214B (en) | Scaffolding | |
EP2640832A4 (en) | NEW ETHIOLOGICAL AGENT | |
PL2654404T3 (pl) | Zraszacz | |
PL2654403T3 (pl) | Zraszacz | |
AU331307S (en) | Scaffold hammer - A | |
AU331308S (en) | Scaffold hammer - B | |
AU331309S (en) | Scaffold hammer - C | |
HK1144141A2 (en) | Scaffold system | |
GB201010620D0 (en) | i C U |